Entities / Company
Olema Pharmaceuticals (United States).
company in San Francisco, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 17
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Olema Pharmaceuticals plans to present mature data on the Palazestrant/ribociclib combination study at ESMO 2025.Some support1 report
-
Olema Pharmaceuticals, headquartered in California, showed potential for a short-term stock rebound on August 13, 2025.Some support1 report
-
Pfizer announced it will supply atirmociclib for a study in collaboration with Olema Pharmaceuticals.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Olema Pharmaceuticals (United States) this week
News at the entities that move Olema Pharmaceuticals (United States) most-
AstraZeneca OperationalAstraZeneca is relocating its registered office from Karnataka to Bengaluru, citing proximity to policy and financial ecosystems.Moves Olema Pharmaceuticals (United States)
-
MarketBeat Mentioned togetherTD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Moves Olema Pharmaceuticals (United States)
-
San Francisco Shared contextMott, CEO of On Ice Rinks, is associated with Union Square in San Francisco.Moves Olema Pharmaceuticals (United States)
-
Cambridge Shared contextCambridge is attracting talent and innovation, with AI and tech companies driving demand for office space.Moves Olema Pharmaceuticals (United States)
-
Nasdaq Shared contextA Vertex employee won an Info-Tech award, the company is listed on Nasdaq, and Sarah Vlasic leads Leadership Circles at the University of Colorado Boulder.Moves Olema Pharmaceuticals (United States)
Connections
The 6 strongest of 17, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Operational
AstraZeneca's trial failures impact investor sentiment for Olema Pharmaceuticals, indicating market competition.
-
Stifel Mentioned together
Stifel provided market coverage for Olema, including a price target reduction based on clinical trial outcomes.
-
MarketBeat Mentioned together
MarketBeat covers Olema Pharmaceuticals by reporting its stock consensus ratings.
-
San Francisco Shared context
Olema Pharmaceuticals maintains its headquarters and conducts financial reporting operations in San Francisco.
-
Cambridge Shared context
Olema Pharmaceuticals maintains an operational presence within the city of Cambridge.
-
Nasdaq Shared context
Olema Pharmaceuticals lists its shares for trading on the Nasdaq exchange.
History
Events by the month they beganSeptember 2026
1 eventJune 2026
3 events- Olema Pharmaceuticals plans to present mature data on the Palazestrant/ribociclib combination study at ESMO 2025.
- Olema Pharmaceuticals, headquartered in California, showed potential for a short-term stock rebound on August 13, 2025.
- Pfizer announced it will supply atirmociclib for a study in collaboration with Olema Pharmaceuticals.